Vivendi SE VIVHY
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 163.32M | 164.18M | 158.58M | 245.45M | 335.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 163.32M | 164.18M | 158.58M | 245.45M | 335.05M |
| Cost of Revenue | 108.49M | 111.72M | 110.46M | 166.42M | 224.14M |
| Gross Profit | 54.83M | 52.46M | 48.12M | 79.03M | 110.92M |
| SG&A Expenses | 111.99M | 115.18M | 113.74M | 174.50M | 237.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 220.48M | 226.90M | 224.20M | 340.92M | 461.30M |
| Operating Income | -57.16M | -62.71M | -65.62M | -95.47M | -126.25M |
| Income Before Tax | 33.83M | 36.83M | 38.28M | -31.54M | -103.55M |
| Income Tax Expenses | 1.17M | 3.42M | 5.47M | 37.98M | 71.51M |
| Earnings from Continuing Operations | 32.66 | 33.40 | 32.81 | -69.52 | -175.06 |
| Earnings from Discontinued Operations | -- | -- | -- | -3.20B | -6.50B |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 18.12M | 36.81M |
| Net Income | 32.66M | 33.40M | 32.81M | -3.25B | -6.64B |
| EBIT | -57.16M | -62.71M | -65.62M | -95.47M | -126.25M |
| EBITDA | -40.83M | -47.15M | -51.40M | 309.96M | 682.65M |
| EPS Basic | 0.07 | 0.07 | 0.07 | -3.25 | -6.67 |
| Normalized Basic EPS | 0.05 | 0.04 | 0.03 | 0.06 | 0.08 |
| EPS Diluted | 0.07 | 0.07 | 0.07 | -3.25 | -6.67 |
| Normalized Diluted EPS | 0.05 | 0.04 | 0.03 | 0.06 | 0.08 |
| Average Basic Shares Outstanding | 3.00B | 3.00B | 2.99B | 2.99B | 3.98B |
| Average Diluted Shares Outstanding | 4.01B | 4.00B | 3.99B | 3.99B | 3.99B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 142.86% | 138.00% | 133.33% | -1.35% | -0.66% |